Literature DB >> 27339447

Genetic and environmental influences on the associations between change in kidney function and changes in cardiometabolic factors in Koreans.

Yun-Mi Song1, Joohon Sung2,3, Kayoung Lee4.   

Abstract

BACKGROUND: This study aimed to evaluate genetic and environmental relations between change in estimated glomerular filtration rate (eGFR) and changes in cardiometabolic factors.
METHODS: In 1772 Korean adults without diabetes and chronic kidney disease at baseline, changes in eGFR using the Chronic Kidney Disease Epidemiology Collaboration equation, blood pressure (BP), fasting serum glucose (FSG), insulin, homeostasis model assessment of insulin resistance index (HOMA-IR), hemoglobin A1c, triglycerides, high and low density lipoprotein cholesterol (HDL and LDL), uric acid, white blood cell (WBC) count, and body mass index (BMI) were calculated as follows: (value at follow-up - value at baseline) × 100/[value at baseline × follow-up interval (years)].
RESULTS: eGFR change was associated with 10 % changes in FSG (Odds ratio, OR = 1.36), uric acid (OR = 2.49), HDL (OR = 0.69), LDL (OR = 1.26), and WBC (OR = 1.15) after adjusting for age, sex, intra-familial and twin correlations, smoking, alcohol use, and physical activity at baseline, and BMI change using a generalized estimating equation. In bivariate variance-component analysis, eGFR change had additive genetic correlations ([Formula: see text]) with changes in insulin (-0.26), HOMA-IR (-0.24), diastolic BP (-0.15), uric acid (-0.45), triglycerides (-0.30), WBC (-0.46), and HDL (0.41), and environmental correlations ([Formula: see text]) with changes in FSG (-0.11), uric acid (-0.32), LDL (-0.14), and WBC (0.10). In co-twin control analyses in 319 monozygotic twin pairs, the ORs for having a greater eGFR decline with a 1 % increase in diastolic BP, uric acid, and LDL were 1.04, 1.09, and 1.03, respectively after adjusting for change in BMI and health behaviors at baseline.
CONCLUSIONS: In these Korean twins and families, additive genetic influences and environmental effects play significant roles in the associations between eGFR change and changes in cardiometabolic factors.

Entities:  

Keywords:  Cardiometabolic trait; Change; GFR; Genetic pleiotropy; Kidney function

Mesh:

Substances:

Year:  2016        PMID: 27339447     DOI: 10.1007/s10157-016-1295-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  28 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project.

Authors:  Jean W MacCluer; Marina Scavini; Vallabh O Shah; Shelley A Cole; Sandra L Laston; V Saroja Voruganti; Susan S Paine; Alfred J Eaton; Anthony G Comuzzie; Francesca Tentori; Dorothy R Pathak; Arlene Bobelu; Jeanette Bobelu; Donica Ghahate; Mildred Waikaniwa; Philip G Zager
Journal:  Am J Kidney Dis       Date:  2010-06-19       Impact factor: 8.860

3.  Healthy Twin: a twin-family study of Korea--protocols and current status.

Authors:  Joohon Sung; Sung-Il Cho; Kayoung Lee; Mina Ha; Eun-Young Choi; Ji-Sook Choi; Ho Kim; Jihae Kim; Kyoung Sue Hong; Yeonju Kim; Keun-Young Yoo; Chan Park; Yun-Mi Song
Journal:  Twin Res Hum Genet       Date:  2006-12       Impact factor: 1.587

4.  A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population.

Authors:  Keita Kamei; Tsuneo Konta; Atsushi Hirayama; Kazuko Suzuki; Kazunobu Ichikawa; Shouichi Fujimoto; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Kenjiro Kimura; Ichiei Narita; Masahide Kondo; Koichi Asahi; Tsuyoshi Watanabe
Journal:  Nephrol Dial Transplant       Date:  2014-07-24       Impact factor: 5.992

5.  Shared and unique genetic effects among seven HDL phenotypes.

Authors:  A G Comuzzie; D L Rainwater; J Blangero; M C Mahaney; J L VandeBerg; J W MacCluer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-05       Impact factor: 8.311

6.  GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.

Authors:  Hiddo J Lambers Heerspink; Hocine Tighiouart; Yingying Sang; Shoshana Ballew; Hasi Mondal; Kunihiro Matsushita; Josef Coresh; Andrew S Levey; Lesley A Inker
Journal:  Am J Kidney Dis       Date:  2014-10-16       Impact factor: 8.860

Review 7.  Conceptual model of CKD: applications and implications.

Authors:  Andrew S Levey; Lesley A Stevens; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

8.  Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Thomas P Erlinger; Josef Coresh; Jane Marsh-Manzi; Aaron R Folsom; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2008-12-24       Impact factor: 8.860

9.  Comparison of heritability of Cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease.

Authors:  Johannes Arpegård; Alexander Viktorin; Zheng Chang; Ulf de Faire; Patrik K E Magnusson; Per Svensson
Journal:  J Am Heart Assoc       Date:  2015-01-14       Impact factor: 5.501

Review 10.  Uric Acid as a Marker of Kidney Disease: Review of the Current Literature.

Authors:  Christin Giordano; Olga Karasik; Kelli King-Morris; Abdo Asmar
Journal:  Dis Markers       Date:  2015-05-27       Impact factor: 3.434

View more
  1 in total

1.  Glomerular Hyperfiltration as Predictor of Cardiometabolic Risk Factors among Children and Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult-V Study.

Authors:  Roya Kelishadi; Mostafa Qorbani; Farahnak Assadi; Mohammad Esmaeil Motlagh; Shirin Djalalinia; Ali Shahsavari; Hasan Ziaodini; Majzoubeh Taheri; Gita Shafiee; Azadeh Aminianfar; Sajjad Esmaeili; Tahereh Aminaei; Morteza Mansourian; Ramin Heshmat
Journal:  Int J Prev Med       Date:  2018-03-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.